ASTN-2 has been implicated via genome-wide association studies in attention-deficit hyperactivity disorder (ADHD) [54], by copy number variant (CNV) analysis of a large human cohort in autism spectrum disorders (ASDs) [55] and in another CNV study in schizophrenia [56]. This evidence concerns the gene ASTN2 and attention deficit-hyperactivity disorder.